News

All 29 member states included in the decentralized procedures supported approval of the product. The authorities’ approval formally acknowledges that Synthon’s glatiramer acetate is regarded therapeutically equivalent to

The licensing agreement also encompasses rights for all therapeutic indications to cirmtuzumab, an anti-ROR1 monoclonal antibody that is currently in a clinical trial for patients with chronic lymphocytic

The product, Arcoral Tab, which EUSA plans to rebrand under the Caphosol name, is a topical oral agent used in the treatment of conditions resulting in reduced salivary

ATI-1501 is the company’s lead drug candidate, which is expected to enter into clinical trials by 2017. The orphan drug status offers seven years of marketing exclusivity after

The company introduced a cloud version of Oracle Health Sciences Safety Suite 8.0, targeting medicinal product manufacturers, trial sponsors, contract research organizations and health authorities. The solution offers

First shipments of this new store brand aseptic shake have already been initiated. This product is packaged and marketed as a store brand or retailer ‘own label’ brand

APD371 is the company’s internally discovered investigational drug candidate aimed at treating pain and potentially other indications. The compound, via its selectivity, is designed to offer pain relief

NMT Pharma has completed due diligence of the CZ-48 drug for cancer treatment in major markets. "This is a new milestone to expand our business from drug delivery

Recipharm has acquired 74 % of the shares for a purchase consideration of INR 6,713 million (SEK 824 million)[1] on a cash and debt free basis. Thomas Eldered,